Herein, we developed a T lymphocyte membrane‐biomimetic magnesium carbonate (MgCO3)/Fe‐CD hybrid nanozyme system loaded with PKM2 activator TEPP‐46, designed to simultaneously induce mitochondrial metabolic reprogramming in both T cells and tumor cells following RT (Scheme1). Here, PKM is linked to neoplasm.